ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,733Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 194

$560K Total Retail Price of All Prescriptions

Rank: 36 out of 194

595 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 13,407 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $36 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,007 889 1 1
LOSARTAN POTASSIUM 863 701 2 3
METOPROLOL SUCCINATE 671 602 3 4
AMLODIPINE BESYLATE 659 537 4 2
ISOSORBIDE MONONITRATE ER 511 461 5 12
HYDROCHLOROTHIAZIDE 438 371 6 13
GABAPENTIN 430 346 7 21
GLIMEPIRIDE 405 334 8 29
LISINOPRIL 354 324 9 11
CLONIDINE HCL 288 237 10 45
ATENOLOL 284 248 11 7
METFORMIN HCL ER 274 228 12 61
METFORMIN HCL 265 233 13 9
ENALAPRIL MALEATE 265 236 13 6
WARFARIN SODIUM 258 242 15 28
CLOPIDOGREL 254 229 16 16
CARVEDILOL 240 221 17 8
LOSARTAN-HYDROCHLOROTHIAZIDE 239 175 18 5
PLAVIX 231 211 19 18
LEVOTHYROXINE SODIUM 218 195 20 20
OMEPRAZOLE 216 164 21 23
FUROSEMIDE 201 156 22 14
DIOVAN 191 176 23 32
RANITIDINE HCL 190 166 24 22
SYNTHROID 189 164 25 17
DIGOXIN 185 159 26 26
AMLODIPINE BESYLATE-BENAZEPRIL 171 149 27 30
ATORVASTATIN CALCIUM 162 141 28 10
TRIAMTERENE-HCTZ 154 145 29 67
PANTOPRAZOLE SODIUM 151 129 30 44
BENAZEPRIL HCL 150 117 31 93
DOXAZOSIN MESYLATE 145 125 32 19
JANUVIA 141 121 33 82
METOPROLOL TARTRATE 129 119 34 15
CRESTOR 126 95 35 27
TRAMADOL HCL-ACETAMINOPHEN 125 100 36 54
FENOFIBRATE 122 103 37 36
ZOLPIDEM TARTRATE 115 110 38 42
ALENDRONATE SODIUM 115 101 38 52
FOSINOPRIL SODIUM 111 90 40 71
COUMADIN 108 104 41 38
LABETALOL HCL 105 75 42 81
VERAPAMIL ER 99 71 43 34
PRAVASTATIN SODIUM 95 59 44 25
GUANFACINE HCL 91 83 R 45 121
SERTRALINE HCL 86 76 46 64
JANUMET 85 63 47 102
DONEPEZIL HCL 83 83 48 76
NITROGLYCERIN PATCH 81 74 49 123
ASPIRIN EC 78 52 50 24
TAMSULOSIN HCL 75 70 51 62
LANTUS 74 48 52 74
LANSOPRAZOLE 73 55 53 79
VYTORIN 73 56 53 53
IRBESARTAN 72 71 55 31
SPIRONOLACTONE 70 52 56 37
FELODIPINE ER 69 69 57 106
GLYBURIDE-METFORMIN HCL 68 59 R 58 56
TORSEMIDE 64 60 59 110
ZETIA 62 37 60 39
SINGULAIR 58 51 61 114
GLIPIZIDE XL 54 43 62 90
HUMULIN N 54 49 62 103
CILOSTAZOL 52 40 64 57
LEVOXYL 51 48 65 59
ATACAND 50 50 66 68
RAMIPRIL 50 46 66 33
MONTELUKAST SODIUM 50 43 66 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.